Navigation Links
Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
Date:1/6/2011

CAMBRIDGE, Mass., Jan. 6, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that the lawsuit filed by Capital Ventures International (CVI) against Verenium has been dismissed.  Verenium's motion for summary judgment to dismiss CVI's complaint was granted by the United States District Court for the Southern District of New York.  CVI's complaint related to a dispute over the terms of Verenium's 8% Senior Convertible Notes (the "Notes"), including the applicable conversion rate under the Notes, is more fully described in Verenium's annual report on Form 10-K for the fiscal year ended December 31, 2009 and subsequently filed quarterly reports on Form 10-Q.

"We are very pleased with this outcome, which confirms we acted in the best interests of the Company and our shareholders in defending our position in this case," said Carlos A. Riva, Chief Executive Officer of Verenium. "We continue to look forward to a successful and productive 2011."  

About VereniumVerenium Corporation is a pioneer in the development and commercialization of high-performance enzymes for use in industrial processes.  Verenium currently sells enzymes developed using its R&D capabilities to industrial customers globally for use in markets including grain and oilseed processing, biofuels, animal health and nutrition and other specialty industrial processes. Verenium has built a world-class R&D organization renowned for its capabilities in the rapid screening, identification, evolution and bioengineering of novel enzymes that act as catalysts for biochemical reactions. The company harnesses the power of nature and uses unique, patented technology to create products that transform industries by maximizing efficiency while improving environmental
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
2. Verenium Reports Financial Results for the Third Quarter 2010
3. Verenium to Present at Jefferies 10th Global Clean Technology Conference
4. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
5. Verenium Announces Regulatory Approval for Purifine® PLC in China
6. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
7. Verenium Appoints Kevin Bracken Vice President of Manufacturing
8. Verenium Announces Proposed Public Offering of Common Stock
9. Verenium 1:12 Reverse Stock Split Takes Effect
10. Verenium Announces Reverse Stock Split to Take Effect September 9
11. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... 14, 2014 The largest international professional organization ... and therapeutic derivatives thereof has endorsed an educational ... about the challenges of adulterated herb and botanical ... The Society for Medicinal Plant and ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... the impact of one of the fastest growing eye diseases on ... provide physicians with a virtual experience of having neovascular (wet) age-related ... ... January 29, 2009 -- To help eye specialists better understand the ...
... a leader in renewable energy and biofuels development and production, today announced ... of the Board of Directors. , ... Los Angeles (PRWEB) January 29, ... and production, today announced the appointment of David Pyrce as its Chief ...
... CHADDS FORD, Pa., Jan. 28 Endo Pharmaceuticals Inc. ... quarter and 2008 full-year financial results on February 27, ... webcast at 10:30 a.m. ET that day to discuss ... Executive Officer, Nancy J. Wysenski, Chief Operating Officer and ...
Cached Biology Technology:Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease 2Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease 3Nexsun Corp Names Industry Executive David Pyrce as Chief Executive Officer 2Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009 2
(Date:4/17/2014)... German . Our ... provide us with a continuous stream of information about our ... still in a car the world glides by us ... without effort, our brain calculates self-motion from this "optic flow". ... steady gaze during our own movements. Together with biologists from ...
(Date:4/17/2014)... Stem cells in bone marrow need to produce hydrogen ... tissue, according to a new study from the Center ... of Dentistry of USC. , Professor Songtao Shi, principal ... sulfide produced by the cells governs the flow of ... cellular signals that results in osteogenesis, or the creation ...
(Date:4/17/2014)... The White House honored Clemson professor Rajendra Singh ... efforts to promote and expand solar deployment in ... the D. Houser Banks Professor of Electrical and ... Silicon Nanoelectronics, is considered a local hero leading ... and economic opportunity in solar power and driving ...
Breaking Biology News(10 mins):How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... cholera that has sickened thousands in Haiti came from a ... over the past three years as some have thought, according ... online open-access journal of the American Society for Microbiology. ... earlier findings that indicate Vibrio cholerae bacteria were ...
... 2013 New materials and potential new drug targets are ... major scientific meeting on the structure of molecules. More information ... in mid-July. The Annual Meeting of the American Crystallographic ... at the Sheraton Waikiki Beach Hotel in Honolulu, Hawaii. Crystallography ...
... The Fondation Leducq in Paris, France, dedicated to improving ... awarded a $6 million grant award to a new ... researchers from the Cardiovascular Research Center at Icahn School ... large grant was awarded as part of the Fondation ...
Cached Biology News:Genomes of cholera bacteria from Haiti confirm epidemic originated from single source 2Genomes of cholera bacteria from Haiti confirm epidemic originated from single source 3New materials, progress toward an HIV vaccine, and more at meeting of crystallographers 2New materials, progress toward an HIV vaccine, and more at meeting of crystallographers 3Fondation Leducq awards $6 million grant for global research network for cardiac regeneration 2Fondation Leducq awards $6 million grant for global research network for cardiac regeneration 3
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
X-gal,1g...
...
Biology Products: